Aardvark Therapeutics Inc.

02/27/2026 | Press release | Distributed by Public on 02/27/2026 15:32

Aardvark Therapeutics Announces Voluntary Pause of Phase 3 HERO Trial in Prader-Willi Syndrome (Form 8-K)

Aardvark Therapeutics Inc. published this content on February 27, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on February 27, 2026 at 21:32 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]